Balance Sheet

v3.25.3

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 243,574	$ 322,399
Accounts receivable, net	22,537	38,520
Inventory	45,326	50,082
Prepaid expenses and other current assets	14,430	18,145
Total current assets	325,867	429,146
Property and equipment, net	158,624	164,474
Goodwill	129,429	159,878
Intangible assets, net	185,876	194,957
Other assets	49,395	59,789
Total assets	849,191	1,008,244
Current liabilities:
Accounts payable	7,998	11,957
Accrued expenses and other current liabilities	48,136	39,574
Current portion of long-term debt	5,440	5,440
Total current liabilities	61,574	56,971
Long-term debt, less current portion	287,381	290,492
Finance lease liabilities, less current portion	30,407	31,106
Other long-term liabilities	37,970	52,466
Total liabilities	417,332	431,035
Commitments and contingencies (Note 8)
Stockholders’ equity:
Additional paid-in capital	196,511	181,874
Retained earnings	45,799	140,891
Accumulated other comprehensive income	579	0
Total stockholders’ equity attributable to Maravai LifeSciences Holdings, Inc.	245,443	325,292
Non-controlling interest	186,416	251,917
Total stockholders’ equity	431,859	577,209
Total liabilities and stockholders’ equity	849,191	1,008,244
Class A Common Stock
Stockholders’ equity:
Common stock	1,447	1,420
Class B Common Stock
Stockholders’ equity:
Common stock	$ 1,107	$ 1,107

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Source